Physicians’ Education Resource ® to Host 15th Annual International Symposium on Melanoma and Other Cutaneous Malignancies ®

Source: Business Wire, January 2019

“We are looking forward to hosting our International Symposium on Melanoma and Other Cutaneous Malignancies^® once again in New York City,” said Phil Talamo, president of PER.^® “Now in its 15th year, the symposium continues to provide physicians with the tools they need to personalize care for every patient they treat with skin and other cutaneous including some very exciting data in the adjuvant setting.”

Throughout the international conference, world-renowned melanoma experts Hamid and Weber, along with distinguished skin cancer specialists, will host several sessions covering topics such as current advances in immunotherapy and targeted therapies, the benefits of regional therapy, how to use predictive and prognostic modeling and how to manage treatment-related adverse events associated with emerging strategies. This symposium will also feature a Medical Crossfire^®, in which the expert panel will address attendees’ questions and participate in a rigorous debate on pressing issues faced by the skin cancer treatment community.

This highly interactive symposium will also feature a special presentation, “We Are What We Eat: How the Microbiome Influences Responses to Immunotherapy in Cancer,” by Thomas F. Gajewski, M.D., Ph.D., AbbVie Foundation professor of cancer immunotherapy at University of Chicago Medicine. Gajewski investigates and develops new treatments for patients with melanoma. He also serves as an editor for Cancer Research and the Journal for Immunotherapy of Cancer.